Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Inhaled corticosteroids in COPD: the clinical evidence.

The European respiratory journal - 1 Feb 2015

Ernst Pierre, Saad Nathalie, Suissa Samy

Abstract excerpt

In this article, we focus on the scientific evidence from randomised trials supporting treatment with inhaled corticosteroids (ICS) in chronic obstructive pulmonary disease (COPD), including treatment with combinations of long-acting β-agonist (LABA) bronchodilators and ICS. Our emphasis is on the methodological strengths and limitations that guide the conclusions that may be drawn. The evidence of benefit of ICS...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Administration, Inhalation
Share to Adrenal Cortex Hormones
Share to Adrenergic beta-2 Receptor Agonists

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Bronchodilator Agents

Share to Eosinophils

Share to Forced Expiratory Volume

Share to Randomized Controlled Trials as Topic

Share to Sputum

Source

Identifiers

PMID: 25537556
DOI: 10.1183/09031936.00128914

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Inhaled corticosteroids in COPD: the clinical evidence.PMID 25537556Read ↗

"Correct use of inhaled corticosteroids in chronic obstructive pulmonary disease": a consensus document.Semantic proximity Read ↗

LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes.Semantic proximity Read ↗

Inhaled corticosteroids in asthma and chronic obstructive pulmonary disease combined phenotype: when to use and what to expect?Semantic proximity Read ↗

Beyond corticosteroids: future prospects in the management of inflammation in COPD.Semantic proximity Read ↗

Pharmacological strategies to reduce exacerbation risk in COPD: a narrative review.Semantic proximity Read ↗

Biological Therapy for Chronic Obstructive Pulmonary Disease (COPD): Efficacy and SafetySemantic proximity Read ↗

Prediction of Long-Term Benefits of Inhaled Steroids by Phenotypic Markers in Moderate-to-Severe COPD: A Randomized Controlled Trial.Semantic proximity Read ↗

Applying the wisdom of stepping down inhaled corticosteroids in patients with COPD: a proposed algorithm for clinical practice.Semantic proximity Read ↗

Inhaled corticosteroids downregulate SARS-CoV-2-related genes in COPD: results from a randomised controlled trialSemantic proximity Read ↗

Significance of Medication History at the Time of Entry into the COPDGene Study: Relationship with Exacerbation and CT Metrics.Semantic proximity Read ↗

Long- versus short-duration systemic corticosteroid regimens for acute exacerbations of COPD: A systematic review and meta-analysis of randomized trials and cohort studiesSemantic proximity Read ↗

Safety of long-acting beta-agonists in asthma: a review.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.